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Validation of the new venous severity scoring
system in varicose vein surgery
Stavros K. Kakkos, MD, MSc,a,b Marco A. Rivera, MD, MSc,a Miltiadis I. Matsagas, MD,a Miltos K.
Lazarides, MD,c Peter Robless, MBChB, FRCS,a Gianni Belcaro, MD, PhD,a and George Geroulakos,
PhD, FRCS,a,d London, United Kingdom; and Alexandroupolis, Greece
Objectives:We performed this observational study to validate the three components of a new venous severity scoring (VSS)
system, ie, venous clinical severity score (VCSS), venous segmental disease score (VSDS), and venous disability score
(VDS), and to evaluate VCSS, VDS, and CEAP clinical class and score in quantifying outcome of varicose vein surgery.
Patients and Methods: The study included 45 patients who underwent superficial venous surgery in 48 legs with primary
varicose veins. Venous color duplex scanning, clinical examination, and a questionnaire were used preoperatively and at
6 weeks and 6 months postoperatively to assign VSS and CEAP clinical class and score.
Results: CEAP clinical score, VCSS, and VDS demonstrated a linear association with CEAP clinical class (P < .001, P <
.001, P  .002, respectively). Good correlation among all severity scores was found, particularly between CEAP clinical
score and VCSS (r  0.94; P < .001). CEAP clinical score was also highly correlated with CEAP clinical class (r  0.84;
P < .001) and VDS (r  0.70; P < .001). Similarly, VCSS correlated with CEAP clinical class (r  0.83; P < .001) and
also VDS (r 0.72; P< .001). The anatomic severity marker VSDS demonstrated a weak correlation with clinical severity
indicators VCSS (r  0.29; P  .048) and VDS (r  0.31; P  .03) but not with age, gender, or CEAP clinical class and
score. Six months after surgery the median (interquartile range) percent change in VCSS (73%; range, 50%-100%) and
CEAP clinical score (70%; range, 50%-100%) were both significantly greater (P < .001) than the corresponding change
in CEAP clinical class (17%; range, 0%-50%). In legs with high VDS at baseline, median (interquartile range) percent
change in VDS was 100% (range, 50%-100%), significantly greater (P < .001) than the corresponding change in CEAP
clinical class (0%; range, 0%-17%).
Conclusions: Venous severity scores are significantly higher in advanced venous disease, demonstrating correlation with
anatomic extent. Both venous clinical severity scores, VCSS and CEAP clinical score, are equally sensitive and significantly
better for measuring changes in response to superficial venous surgery than is the already in use CEAP clinical class. VDS
demonstrated comparable and even better performance. Although the assignment of CEAP clinical class might be
adequate for daily clinical purposes, venous severity scoring systems should be used in clinical studies to quantify venous
outcome. (J Vasc Surg 2003;38:224-8.)
Varicose vein prevalence and the number of operations
performed worldwide for that reason classify varicosities as
the most common vascular disease. Inasmuch as several
related issues are controversial, studies and trials of venous
disease are still necessary. Reliable outcome assessment is of
paramount importance for those studies, although the
methods currently in use are more qualitative than quanti-
tative and therefore probably not sensitive enough to gauge
treatment.1,2 This could explain the existence of several
classification and scoring systems, including specialized
quality of life questionnaires; however, the ideal method
remains to be established.1-5
The established CEAP (Clinical, Etiologic, Anatomic,
Pathophysiologic) classification system for chronic venous
disease has been successfully used to classify stages of ve-
nous disease, enabling patient comparison among different
centers and studies.1 The CEAP clinical class has seven
categories, ie, C0 to C6. However, CEAP clinical class is
not particularly useful for outcome measurements, because
it is only a 7-point score and because some of its compo-
nents are static (C4, C5) and therefore not sensitive to
demonstrate changes after therapeutic measures. For those
reasons, an 18-point clinical score and disability score was
introduced.6
A new venous severity scoring (VSS) system has been
recently proposed by the American Venous Forum AdHoc
Committee on Venous Outcomes Assessment as a useful
and reliable method for outcome quantification, compari-
son of different management approaches, and reports in the
management of chronic venous disease (CVD).7 The pro-
posed system has three elements: venous clinical severity
score (VCSS), which is a modification to replace CEAP
clinical score; venous segmental disease score (VSDS),
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which is a combination of the anatomic and pathophysio-
logic components of CEAP; and venous disability score
(VDS), a modification of the original CEAP disability
score. It is believed that these three components together
can be used as an integrated and improved method for
assessing venous outcome.6
The purpose of the present study was to validate VSS
components and to compare VCSS and VDS with clinical
class, clinical score, and disability score of the CEAP system
in quantifying outcome of varicose vein surgery.
MATERIAL AND METHODS
Forty-seven consecutive patients with primary symp-
tomatic varicose veins, undergoing superficial vein surgery
in 50 legs, participated in the study. All patients gave
informed consent. After excluding 2 patients not available
for follow-up because they had both moved out of the area,
complete follow-up data were available for statistical anal-
ysis for 45 patients (48 legs, 96%). Clinical examination and
a questionnaire were used preoperatively for each patient to
assess the following:
1. CEAP clinical class1 (Table I, online only)
2. The 18-point CEAP clinical score6 (Table II, online
only)
3. VCSS7 (Table III, online only)
4. The 3-point CEAP disability score (0  asymptomatic;
1 symptomatic, can function without support device;
2 can work 8-hour day only with support device; 3
unable to work even with support device) and its mod-
ification, VDS (0  asymptomatic; 1  symptomatic
but able to carry out usual activities [ie, activities per-
formed before onset of disability from venous disease]
without compressive therapy; 2  can carry out usual
activities only with compression and/or limb elevation;
3  unable to carry out usual activities even with com-
pression and/or limb elevation)7
The differences between CEAP clinical score and VCSS
are shown in Table IV.
Color duplex scanning was performed to assign VSDS
for reflux; this is the sum of the scores assigned for each
individual venous segment, as follows: short saphenous,
0.5; long saphenous, 1; thigh perforators, 0.5; calf perfora-
tors, 1; multiple calf veins, 2 (posterior tibial alone, 1);
popliteal vein, 2; superficial femoral vein, 1; profunda fem-
oris vein, 1; common femoral vein and above, 1. Maximum
reflux score was 10.7 Because postthrombotic legs were not
included in our study, we did not calculate the proposed
VSDS for obstruction.7
Thirty-eight legs underwent surgery of the long saphe-
nous system only, involving flush saphenofemoral ligation
and stripping of the long saphenous vein to below the knee.
Eight legs underwent short saphenous vein surgery only,
involving saphenopopliteal junction ligation. In 2 legs both
saphenous systems were managed as described. In addition,
avulsion phlebectomy was performed in all patients.
Patients were followed-up postoperatively at 6 weeks
and 6 months to assign VCSS, VDS, and CEAP clinical
class and score.
The Kolmogorov-Smirnov test was used to test data for
normal distribution. Nonparametric statistical tests (Wil-
coxon signed rank test, Mann-Whitney U test, Kruskal-
Wallis test, Spearman rank correlation, and Kendall’s tau-b
test) were used. SPSS for Windows (version 11; SPSS Inc,
Chicago, Ill) was used for statistical analysis. P  .05 was
considered statistically significant.
RESULTS
Median patient age was 51 years (range, 19-86 years),
and 23 patients were men. Thirty-one legs (65%) were
classified in CEAP clinical classes 4 to 6.
Score intercorrelation. CEAP clinical score, VCSS,
and VDS were all increased linearly in advanced CEAP
clinical class (r 0.84, r 0.83, r 0.5, respectively; all P
 .001); similar results were obtained with the Kruskal-
Wallis test (Fig 1). For example, median VCSS increased
progressively from 3 in CEAP clinical class 2 to 13.5 in
CEAP clinical class 6; the other scores demonstrated the
same pattern.
No significant relationship was found between gender
or age with preoperative CEAP clinical class or score,
VCSS, or VDS (all P  .05, Spearman correlation or
Mann-Whitney test). However, a significant correlation
among all severity scores was found, particularly between
CEAP clinical score and VCSS (r  0.94; P  .001).
Similarly, CEAP clinical score was correlated with CEAP
clinical class (r 0.84; P .001) and VDS (r 0.70; P
.001). VCSS was also correlated with CEAP clinical class (r
 0.83; P  .001) and VDS (r  0.72; P  .001). CEAP
disability score showed agreement with VDS in all but two
cases (Kendall’s tau-b 0.95; approximate T, 12.1; P 
.001); thus no further correlations were performed.
Association between clinical and anatomic scores.
Median VSDS for reflux was 1 (range, 0-3.5); superficial
venous reflux and incompetent perforator veins accounted
Table IV. Comparison of CEAP clinical score and VCSS








Ulcer size Ulcer size
Ulcer duration Ulcer duration




VCSS, Venous clinical severity score.
*Maximum score, 18.
†Maximum score, 30.
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for all but one case, with coexisting reflux in the deep
venous system, confined to the posterior tibial veins. No
association was found between VSDS and age (r 0.12; P
 .44), gender, or CEAP clinical class (r  0.10; P  .49)
and score (r 0.25; P .09). However, a weak association
was found between VSDS and VCSS (r  0.29; P  .048;
Fig 2) and VDS (r  0.31; P  .03).
Score change after surgery. CEAP clinical class and
score, VCSS, and VDS all significantly changed at 6 weeks
and 6 months in comparison with preoperative values (Fig
3). Although median CEAP clinical class did not change
(Fig 3), its distribution changed significantly, as a result of
the change demonstrated in legs with CEAP class 2 or 3
disease. In contrast, median CEAP clinical class did not
change in legs with CEAP class 4 to 6 disease (Fig 4).
The percentage of change between preoperative and
postoperative values of the clinical severity scoring systems
was used as a measurement of the sensitivity of each assess-
ment tool. These values were related to their respective
preoperative VCSS levels. Score changes after surgery were
already evident at week 6 and remained stable after 6
months (Table V). Overall change was about 70% in the
case of CEAP clinical score and VCSS, and was only 17% in
the case of CEAP clinical class (all P .001). The difference
between percentage change in CEAP clinical score and
VCSS at 6months was not statistically significant (P .45).
Median VDS change (100%) at 6 months was statistically
significant only in legs with baseline VDS score more than
0 (Table V). Legs with CEAP class 2 or 3 disease demon-
strated significantly greater changes in VCSS at 6 weeks and
with all four scoring methods (CEAP clinical score and
class, VCSS, and VDS) at 6 months (P  .003, .001,
.001, .017, respectively), compared with legs with CEAP
class 4 to 6 disease (Fig 5). No association was found
between VSDS and postoperative score change (P  .05).
DISCUSSION
Assessment of venous outcome has been the subject of
several reports and studies1-6; however, introduction of
new or improved methods, including instruments of qual-
ity of life, implies that there is no universally accepted
system. As a reflection of this, the American Venous Forum
Ad Hoc Committee on Venous Outcomes Assessment
recently introduced a venous severity scoring system, stat-
ing that “the widespread use of a properly designed disease
severity scoring scheme should allow patient groups of
similar degrees of severity to be selected for entry into
clinical trials and to be compared in regard to outcome
following different therapies”.7 The committee’s intention
was that the new scoring scheme be viewed as complemen-
tary to the current CEAP system; this is probably true for
CEAP clinical class, which is simple and therefore suitable
for everyday clinical purposes.
We found a linear association of both CEAP clinical
score and VCSS with CEAP clinical class, a traditional
indicator of venous disease severity. Similar median VCSS
values and overall association of VCSS with CEAP clinical
class have been reported by Meissner et al,8 supporting the
validity of these scores. These authors also reported excel-
lent performance of VCSS in differentiating normal legs
from those with venous disease, and legs with severe venous
disease from those with moderate venous disease or normal
legs (area under curve with receiver operating characteris-
Fig 1. Median CEAP clinical score, venous clinical severity score
(VCSS), and venous disability score (VDS) in relation to chronic
venous insufficiency severity, as classified with CEAP clinical class
(P  .001, P  .001, P  .008; Kruskal-Wallis test).
Table V. Percent change in CEAP clinical class and score, VCSS, and VDS at 6 wk and 6 mo postoperatively
Follow-up
6 wk 6 mo
Median Interquartile range Median Interquartile range
CEAP clinical class 0 0-16.7 16.67 0-100
CEAP clinical score 66.67 22.9-87.1* 70 50-100*
VCSS 66.67 50-84.3* 73.33 50-100*
VDS
All patients 50 0-100* 100 0-100
VDS 0 100 0-100* 100 50-100*
VCSS, Venous clinical severity score; VDS, venous disability score.
*Statistical significance in comparison with CEAP clinical class (all P  0.01).
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tics curve method, 0.94 and 0.93, respectively).8 Using the
same method, we found similar results (data not shown) in
differentiating mild and moderate venous disease (CEAP
clinical class 2-3) from severe venous disease (CEAP clinical
class 4-6). This was found for VCSS, CEAP clinical score,
and VDS (area under curve, 0.93, P  .001; 0.92, P 
.001; 0.72, P  .012, respectively).
Similar to VCSS, VDS followed the same linear, al-
though not so robust, pattern as CEAP clinical class; per-
haps other factors influence that association. The good
correlation between CEAP clinical score and VCSS that we
found indicates that to some extent both scores are based
on common characteristics. This rather expected finding is
apparent in Table IV. Patient age and gender are known
demographic factors related to venous disease.9 The lack of
association of all classification scores with age and gender
enhances further their validity, and could reflect our selec-
tion criteria, ie, surgery for primary varicose veins. The
similarity between VDS and CEAP disability score was
rather expected, inasmuch as VDS represents a modifica-
tion of CEAP disability score, referring to patient usual
activities.
A statistically significant, although weak, association
between VSDS and the new clinical scores VDS and VCSS
was found, the two scores being higher in patients with
increased number of venous segments with reflux; the
magnitude of reflux correlates with symptom severity.10
Although this correlation was expected, it was not observed
with the CEAP system. This could indicate superiority of
VSS scores in comparison with CEAP scores. The CEAP
spectrum in our study was wide- ranging enough, with 15
legs classified as C5 or 6.
Postthrombotic legs with high VSDS, which could
improve the statistical associations, were not included in
this study. This could explain the relatively weak association
between anatomic and clinical factors, and supports previ-
ous hypotheses that venous ulceration is a multifactorial
process.11
VCSS and CEAP clinical score, reduced by 70% at 6
months postoperatively, demonstrated equally good sensi-
tivity in measuring venous outcome. Postoperative changes
were mainly due to varicose vein removal and pain reduc-
tion, whereas the observed modest score improvement in
CEAP clinical class 4 to 6 reflects the existence of static
components, eg, induration and skin pigmentation. New
Fig 2. Scatterplot shows linear association between venous seg-
mental disease score (VSDS) and venous clinical severity score
(VCSS) (r  0.29; P  .048).
Fig 3. Median CEAP clinical class and score, venous clinical severity score (VCSS), and venous disability score (VDS),
before and after superficial surgery.
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research and larger series are needed to decide which factors
can be removed from the VCSS to make it easier and
simpler without loosing sensitivity. Although assessment of
reproducibility was beyond the scope of this study, satisfac-
tory results have been reported.8
Both VCSS and CEAP clinical score changes were
significantly higher in comparison with those of CEAP
clinical class, which is considered rather static. Although we
foundCEAP clinical class nonsensitive inmeasuring venous
outcome, we still consider CEAP clinical class useful in
classifying clinical stages. This was also the intention of the
VSS inventors, to complement the current CEAP system.7
VDS changes were found to be superior to all other scores;
however, this finding needs to be treated with caution,
because patient expectations to be compression-free might
be a potential bias toward no use of elastic compression.
Nevertheless, VDS is simple and probably has a strong
relation with quality of life. VSS neither takes into account
quality of life issues nor intends to substitute the specially
designed quality of life questionnaires. Our opinion is that
neither system is superior and that a new, hybrid system
needs to be devised. Quality of life is not always affected,
and in those cases these systems are not useful.
In conclusion, clinical severity scores, especially the new
VCSS, are useful tools for assessing venous outcome. Com-
pared with CEAP clinical score, VCSS has the additional
advantage of correlating better with VSDS, a measure of
the anatomic pattern of venous disease. Further modifica-
tions in VCSS might increase its sensitivity in monitoring
outcome of venous surgery. Although use of the relatively
simple CEAP clinical class might be adequate for daily
clinical purposes, venous severity scoring systems should be
used in clinical studies to quantify venous outcome.
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Fig 4. Median CEAP clinical class before and after surgery in
patients stratified by CEAP clinical class.
Fig 5. Top, Percent change in CEAP clinical score and class,
venous clinical severity score (VCSS), and venous disability score
(VDS), at 6 weeks after surgery. Patients were stratified according
to CEAP clinical class. Bottom, Percent change in CEAP clinical
score and class, VCSS, and VDS, at 6months after surgery. Patients
were stratified according to CEAP clinical class.
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Table I, online only. CEAP clinical class categories
Class 0: no visible or palpable signs of venous disease
Class 1: telangiectases, reticular veins, malleolar flare
Class 2: varicose veins
Class 3: edema
Class 4: skin changes ascribed to venous disease
Class 5: skin changes in conjunction with healed ulceration
Class 6: skin changes in conjunction with active ulceration




Pain None Moderate, not necessitating analgesics Severe, necessitating analgesics
Edema None Mild or moderate Severe
Venous claudication None Mild or moderate Severe
Pigmentation None Localized Extensive
Lipodermatosclerosis None Localized Extensive
Ulcer diameter (cm) None 2 2
Ulcer duration (mo) None 3 3
Ulcer recurrence None Once More than once
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Table III, online only. Attributes of new venous clinical severity score*
Attribute Absent  0 Mild  1 Moderate  2 Severe  3






Daily, severe, limiting activities or
requiring regular use of
analgesics
Varicose veins† None Few, scattered; branch
varicose veins
Multiple: GS varicose veins
confined to calf or thigh
Extensive: Thigh and calf or GS
and LS distribution
Venous edema‡ None Evening ankle edema only Afternoon edema, above
ankle
Morning edema above ankle and
requiring activity change,
elevation
Skin pigmentation§ None or focal, low
intensity (tan)
Diffuse but limited in area,
and old (brown)




Wider distribution (above lower
1/3) and recent pigmentation




involving most of gaiter
area (lower 1/3)
Severe cellulitis (lower 1/3 and
above) or significant venous
eczema
Induration None Focal, circummalleolar (5
cm)
Medial or lateral, less than
lower third of leg
Entire lower third of leg or more
No. of active ulcers 0 1 2 2
Active ulceration, duration None 3 mo 3 mo, 1 y Not healed 1 y
Active ulcer, size None 2 cm diameter 2-6 cm diameter 6 cm diameter




Use of elastic stockings most
days
Full compliance: stockings plus
elevation
Reprinted with permission from Rutherford RB et al. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12.
GS, Greater saphenous vein; LS, lesser saphenous vein.
*Proposed by American Venous Forum Ad Hoc Committee on Venous Outcomes Assessment.
†“Varicose” veins must be 4 mm in diameter to qualify, so that differentiation is ensured between C1 and C2 venous disease.
‡Presumes venous origin by characteristics (eg, brawny [not pitting or spongy] edema), with significant effect of standing or limb elevation or other clinical evidence of venous cause (ie, varicose veins, history of deep
venous thrombosis). Edema must be a regular finding (eg, daily occurrence). Occasional or mild edema does not qualify.
§Focal pigmentation over varicose veins does not qualify.
Largest dimensions diameter of largest ulcer.
¶Sliding scale to adjust for background differences in use of compressive therapy.
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